Why is Remus Pharma. falling/rising?

As of 03-Nov, Remus Pharmaceuticals Ltd is experiencing a price increase, with its current price at 770.05, reflecting a rise of 50.0 or 6.94%. The stock has shown strong performance today, outperforming its sector by 5.64%. In terms of returns, over the past week, the stock has increased by 15.07%, while it has seen a more modest gain of 5.42% over the past month. However, it is important to note that the stock has significantly underperformed on a year-to-date basis, with a decline of 38.33%, and a yearly decline of 41.49%. The stock's moving averages indicate that while it is currently above the 5-day and 20-day averages, it remains below the longer-term averages of 50-day, 100-day, and 200-day, suggesting mixed signals regarding its longer-term trend. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 35.75% against the 5-day average, which could indicate waning interest despite the recent price rise.
Broader market context shows that while Remus Pharmaceuticals has outperformed the Sensex by a significant margin in the short term, the broader market has been relatively stable, with the Sensex showing a slight decline of 0.78% over the past week. This contrast highlights the stock's recent strength amidst a generally weaker market environment. However, the year-to-date and yearly performance of Remus Pharmaceuticals remains concerning compared to the Sensex, which has gained 8.96% year-to-date and 6.00% over the past year. The liquidity of the stock appears sufficient for trading, but the falling delivery volume may raise concerns about sustained interest from investors moving forward.